Citi: Maintains the Zymeworks (ZYME.US) rating, adjusted from buy to buy rating, and adjusted the target price from $17.00 to $16.00.
Zhitong FinanceMay 4 06:01
Zymeworks Analyst Ratings
BenzingaMay 4 02:03
Wells Fargo Maintains Overweight on Zymeworks, Lowers Price Target to $12
BenzingaMay 4 02:04
Buy Rating Affirmed for Zymeworks on Strong Pipeline and Upcoming Catalysts
TipRanksMay 3 18:40
Maintaining Hold on Zymeworks: ZW191's Potential Amidst Competitive and Regulatory Hurdles
TipRanksApr 12 18:27
Analysts' Top Healthcare Picks: Zymeworks (ZYME), 89bio (ETNB)
TipRanksMar 13 22:00
Zymeworks Analyst Ratings
BenzingaMar 12 19:16
Buy Rating Affirmed for Zymeworks Amid Positive HERIZON Study Outlook and Robust Commercial Prospects of Zanidatamab
TipRanksMar 12 17:16
Stifel Nicolaus Keeps Their Buy Rating on Zymeworks (ZYME)
TipRanksMar 12 10:05
Zymeworks Analyst Ratings
BenzingaMar 11 18:40
Hold Rating on Zymeworks Amidst Pipeline Adjustments and Clinical Validation Awaited
TipRanksMar 11 12:46
Hold Rating on Zymeworks Amid Anticipation of Future Clinical Trial Outcomes
TipRanksJan 5 19:28
Analysts' Opinions Are Mixed on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Zymeworks (ZYME) and Aclaris Therapeutics (ACRS)
TipRanksNov 13, 2023 19:20
Hold Rating for Zymeworks Amid New Preclinical Candidate, Regained Rights, and Anticipated Pipeline Progress: A Comprehensive Financial Analysis
TipRanksNov 10, 2023 19:30
HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $8 Price Target
BenzingaAug 15, 2023 19:14
Zymeworks Analyst Ratings
BenzingaAug 15, 2023 19:13
H.C. Wainwright Sticks to Its Hold Rating for Zymeworks (ZYME)
TipRanksAug 15, 2023 18:36
Zymeworks (ZYME) Receives a Buy From Stifel Nicolaus
TipRanksJun 7, 2023 10:16
Zymeworks (ZYME) Receives a Hold From H.C. Wainwright
TipRanksJun 6, 2023 18:25
HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $8 Price Target
BenzingaJun 6, 2023 18:18
No Data
No Data